SCHEMBL5356201

SCHEMBL5356201

NCCCCCN1C(=O)c2ccccc2Oc2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 4/20 0.66
TUBB4A P04350 4/20 0.66
TUBB P07437 4/20 0.66
TUBA3C P0DPH7 4/20 0.66
HDAC4 P56524 4/20 0.66
TUBA1B P68363 4/20 0.66
TUBA4A P68366 4/20 0.66
TUBB4B P68371 4/20 0.66
TUBB3 Q13509 4/20 0.66
HDAC1 Q13547 4/20 0.66
TUBB2A Q13885 4/20 0.66
TUBB8 Q3ZCM7 4/20 0.66
TUBA3E Q6PEY2 4/20 0.66
TUBA1A Q71U36 4/20 0.66
HDAC7 Q8WUI4 4/20 0.66
HDAC2 Q92769 4/20 0.66
HDAC10 Q969S8 4/20 0.66
HDAC11 Q96DB2 4/20 0.66
TUBA1C Q9BQE3 4/20 0.66
TUBB6 Q9BUF5 4/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1367274 0.86 HDAC8 (0.66) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL5464107 0.86 HDAC8 (0.66) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL13461615 0.83 PIM1 (0.59) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL16566438 0.82 HDAC3 (0.64) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL5462204 0.81 HDAC3 (0.60) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL14345593 0.81 HDAC8 (0.60) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL1367877 0.80 HDAC8 (1.00) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL2143790 0.80 HDAC8 (1.00) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL2144150 0.80 HDAC8 (1.00) HDAC3TUBB4ATUBBTUBA3CHDAC4
SCHEMBL1366285 0.80 HDAC3 (0.61) HDAC3TUBB4ATUBBTUBA3CHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143822-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-21 WO disclosed
WO-2007143822-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-21 WO disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HDAC3 4/4885TUBB4A 3491/4885TUBB 1771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.